Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry

Rapid mutations of proteins that are targeted in cancer therapy often lead to drug resistance. Often, the mutation directly affects a drug’s binding site, effectively blocking binding of the drug, but these mutations can have other effects such as changing the protein turnover half-life. Utilizing S...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael J. Greig, Sherry Niessen, Scott L. Weinrich, Jun Li Feng, Manli Shi, Ted O. Johnson
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2015/798936
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565230371078144
author Michael J. Greig
Sherry Niessen
Scott L. Weinrich
Jun Li Feng
Manli Shi
Ted O. Johnson
author_facet Michael J. Greig
Sherry Niessen
Scott L. Weinrich
Jun Li Feng
Manli Shi
Ted O. Johnson
author_sort Michael J. Greig
collection DOAJ
description Rapid mutations of proteins that are targeted in cancer therapy often lead to drug resistance. Often, the mutation directly affects a drug’s binding site, effectively blocking binding of the drug, but these mutations can have other effects such as changing the protein turnover half-life. Utilizing SILAC MS, we measured the cellular turnover rates of an important non-small cell lung cancer target, epidermal growth factor receptor (EGFR). Wild-type (WT) EGFR, EGFR with a single activating mutant (Del 746–750 or L858R), and the drug-resistant double mutant (L858R/T790M) EGFR were analyzed. In non-small cell lung cancer cell lines, EGFR turnover rates ranged from 28 hours in A431 cells (WT) to 7.5 hours in the PC-9 cells (Del 746–750 mutant). The measurement of EGFR turnover rate in PC-9 cells dosed with irreversible inhibitors has additional complexity due to inhibitor effects on cell viability and results were reported as a range. Finally, essential amino acid recycling (K and R) was measured in different cell lines. The recycling was different in each cell line, but the overall inclusion of the effect of amino acid recycling on calculating EGFR turnover rates resulted in a 10–20% reduction in rates.
format Article
id doaj-art-4cdd757837e142f3bc96408a4ac0c80a
institution Kabale University
issn 1687-8876
1687-8884
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-4cdd757837e142f3bc96408a4ac0c80a2025-02-03T01:08:50ZengWileyInternational Journal of Cell Biology1687-88761687-88842015-01-01201510.1155/2015/798936798936Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass SpectrometryMichael J. Greig0Sherry Niessen1Scott L. Weinrich2Jun Li Feng3Manli Shi4Ted O. Johnson5Worldwide Medicinal Chemistry, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USAWorldwide Medicinal Chemistry, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USAOncology Research Unit, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USAWorldwide Medicinal Chemistry, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USAOncology Research Unit, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USAWorldwide Medicinal Chemistry, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USARapid mutations of proteins that are targeted in cancer therapy often lead to drug resistance. Often, the mutation directly affects a drug’s binding site, effectively blocking binding of the drug, but these mutations can have other effects such as changing the protein turnover half-life. Utilizing SILAC MS, we measured the cellular turnover rates of an important non-small cell lung cancer target, epidermal growth factor receptor (EGFR). Wild-type (WT) EGFR, EGFR with a single activating mutant (Del 746–750 or L858R), and the drug-resistant double mutant (L858R/T790M) EGFR were analyzed. In non-small cell lung cancer cell lines, EGFR turnover rates ranged from 28 hours in A431 cells (WT) to 7.5 hours in the PC-9 cells (Del 746–750 mutant). The measurement of EGFR turnover rate in PC-9 cells dosed with irreversible inhibitors has additional complexity due to inhibitor effects on cell viability and results were reported as a range. Finally, essential amino acid recycling (K and R) was measured in different cell lines. The recycling was different in each cell line, but the overall inclusion of the effect of amino acid recycling on calculating EGFR turnover rates resulted in a 10–20% reduction in rates.http://dx.doi.org/10.1155/2015/798936
spellingShingle Michael J. Greig
Sherry Niessen
Scott L. Weinrich
Jun Li Feng
Manli Shi
Ted O. Johnson
Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry
International Journal of Cell Biology
title Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry
title_full Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry
title_fullStr Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry
title_full_unstemmed Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry
title_short Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry
title_sort effects of activating mutations on egfr cellular protein turnover and amino acid recycling determined using silac mass spectrometry
url http://dx.doi.org/10.1155/2015/798936
work_keys_str_mv AT michaeljgreig effectsofactivatingmutationsonegfrcellularproteinturnoverandaminoacidrecyclingdeterminedusingsilacmassspectrometry
AT sherryniessen effectsofactivatingmutationsonegfrcellularproteinturnoverandaminoacidrecyclingdeterminedusingsilacmassspectrometry
AT scottlweinrich effectsofactivatingmutationsonegfrcellularproteinturnoverandaminoacidrecyclingdeterminedusingsilacmassspectrometry
AT junlifeng effectsofactivatingmutationsonegfrcellularproteinturnoverandaminoacidrecyclingdeterminedusingsilacmassspectrometry
AT manlishi effectsofactivatingmutationsonegfrcellularproteinturnoverandaminoacidrecyclingdeterminedusingsilacmassspectrometry
AT tedojohnson effectsofactivatingmutationsonegfrcellularproteinturnoverandaminoacidrecyclingdeterminedusingsilacmassspectrometry